FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912196744> ?p ?o ?g. }

• W2912196744 endingPage "222" @default.
• W2912196744 startingPage "215" @default.
• W2912196744 abstract "This study was performed to determine whether neoadjuvant treatment increases survival in patients with BRPC.Despite many promising retrospective data on the effect of neoadjuvant treatment for borderline resectable pancreatic cancer (BRPC), no high-level evidence exists to support the role of such treatment.This phase 2/3 multicenter randomized controlled trial was designed to enroll 110 patients with BRPC who were randomly assigned to gemcitabine-based neoadjuvant chemoradiation treatment (54 Gray external beam radiation) followed by surgery or upfront surgery followed by chemoradiation treatment from four large-volume centers in Korea. The primary endpoint was the 2-year survival rate (2-YSR). Interim analysis was planned at the time of 50% case enrollment.After excluding the patients who withdrew consent (n = 8) from the 58 enrolled patients, 27 patients were allocated to neoadjuvant treatment and 23 to upfront surgery groups. The overall 2-YSR was 34.0% with a median survival of 16 months. In the intention-to-treat analysis, the 2-YSR and median survival were significantly better in the neoadjuvant chemoradiation than the upfront surgery group [40.7%, 21 months vs 26.1%, 12 months, hazard ratio 1.495 (95% confidence interval 0.66-3.36), P = 0.028]. R0 resection rate was also significantly higher in the neoadjuvant chemoradiation group than upfront surgery (n = 14, 51.8% vs n = 6, 26.1%, P = 0.004). The safety monitoring committee decided on early termination of the study on the basis of the statistical significance of neoadjuvant treatment efficacy.This is the first prospective randomized controlled trial on the oncological benefits of neoadjuvant treatment in BRPC. Compared to upfront surgery, neoadjuvant chemoradiation provides oncological benefits in patients with BRPC." @default.
• W2912196744 created "2019-02-21" @default.
• W2912196744 creator A5000062698 @default.
• W2912196744 creator A5003510838 @default.
• W2912196744 creator A5006877581 @default.
• W2912196744 creator A5013664294 @default.
• W2912196744 creator A5024933931 @default.
• W2912196744 creator A5025322881 @default.
• W2912196744 creator A5029996030 @default.
• W2912196744 creator A5034683497 @default.
• W2912196744 creator A5042323474 @default.
• W2912196744 creator A5045587524 @default.
• W2912196744 creator A5053320499 @default.
• W2912196744 creator A5056963227 @default.
• W2912196744 creator A5057582488 @default.
• W2912196744 creator A5057589182 @default.
• W2912196744 creator A5071276908 @default.
• W2912196744 creator A5078630835 @default.
• W2912196744 creator A5079104635 @default.
• W2912196744 creator A5083670170 @default.
• W2912196744 creator A5090608424 @default.
• W2912196744 date "2018-08-01" @default.
• W2912196744 modified "2023-10-16" @default.
• W2912196744 title "Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer" @default.
• W2912196744 cites W1606503260 @default.
• W2912196744 cites W1978651988 @default.
• W2912196744 cites W1990383064 @default.
• W2912196744 cites W1994177577 @default.
• W2912196744 cites W1996255196 @default.
• W2912196744 cites W2007157062 @default.
• W2912196744 cites W2015083350 @default.
• W2912196744 cites W2018622584 @default.
• W2912196744 cites W2024477013 @default.
• W2912196744 cites W2030126221 @default.
• W2912196744 cites W2043301107 @default.
• W2912196744 cites W2044211072 @default.
• W2912196744 cites W2044982012 @default.
• W2912196744 cites W2061274398 @default.
• W2912196744 cites W2066420835 @default.
• W2912196744 cites W2091405318 @default.
• W2912196744 cites W2160273106 @default.
• W2912196744 cites W2167628315 @default.
• W2912196744 cites W2172087239 @default.
• W2912196744 cites W2184708375 @default.
• W2912196744 cites W2267469086 @default.
• W2912196744 cites W2329853068 @default.
• W2912196744 cites W2333477133 @default.
• W2912196744 cites W2409856225 @default.
• W2912196744 cites W2588955174 @default.
• W2912196744 cites W2765450863 @default.
• W2912196744 cites W592682419 @default.
• W2912196744 doi "https://doi.org/10.1097/sla.0000000000002705" @default.
• W2912196744 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29462005" @default.
• W2912196744 hasPublicationYear "2018" @default.
• W2912196744 type Work @default.
• W2912196744 sameAs 2912196744 @default.
• W2912196744 citedByCount "446" @default.
• W2912196744 countsByYear W29121967442018 @default.
• W2912196744 countsByYear W29121967442019 @default.
• W2912196744 countsByYear W29121967442020 @default.
• W2912196744 countsByYear W29121967442021 @default.
• W2912196744 countsByYear W29121967442022 @default.
• W2912196744 countsByYear W29121967442023 @default.
• W2912196744 crossrefType "journal-article" @default.
• W2912196744 hasAuthorship W2912196744A5000062698 @default.
• W2912196744 hasAuthorship W2912196744A5003510838 @default.
• W2912196744 hasAuthorship W2912196744A5006877581 @default.
• W2912196744 hasAuthorship W2912196744A5013664294 @default.
• W2912196744 hasAuthorship W2912196744A5024933931 @default.
• W2912196744 hasAuthorship W2912196744A5025322881 @default.
• W2912196744 hasAuthorship W2912196744A5029996030 @default.
• W2912196744 hasAuthorship W2912196744A5034683497 @default.
• W2912196744 hasAuthorship W2912196744A5042323474 @default.
• W2912196744 hasAuthorship W2912196744A5045587524 @default.
• W2912196744 hasAuthorship W2912196744A5053320499 @default.
• W2912196744 hasAuthorship W2912196744A5056963227 @default.
• W2912196744 hasAuthorship W2912196744A5057582488 @default.
• W2912196744 hasAuthorship W2912196744A5057589182 @default.
• W2912196744 hasAuthorship W2912196744A5071276908 @default.
• W2912196744 hasAuthorship W2912196744A5078630835 @default.
• W2912196744 hasAuthorship W2912196744A5079104635 @default.
• W2912196744 hasAuthorship W2912196744A5083670170 @default.
• W2912196744 hasAuthorship W2912196744A5090608424 @default.
• W2912196744 hasConcept C121608353 @default.
• W2912196744 hasConcept C126322002 @default.
• W2912196744 hasConcept C141071460 @default.
• W2912196744 hasConcept C143998085 @default.
• W2912196744 hasConcept C168563851 @default.
• W2912196744 hasConcept C187960798 @default.
• W2912196744 hasConcept C203092338 @default.
• W2912196744 hasConcept C207103383 @default.
• W2912196744 hasConcept C2776694085 @default.
• W2912196744 hasConcept C2778292576 @default.
• W2912196744 hasConcept C2778424827 @default.
• W2912196744 hasConcept C2780210213 @default.
• W2912196744 hasConcept C2780258809 @default.
• W2912196744 hasConcept C44249647 @default.
• W2912196744 hasConcept C509974204 @default.

• next